COVID-19: New Emergency Guidance From AAMI Targets Remote-Controlled Devices
Executive Summary
Consensus report CR511 from the Association for the Advancement of Medical Instrumentation highlights common system elements for engineers, and outlines safety and risk-control measures that manufacturers and caregivers should consider.
You may also be interested in...
COVID-19: FDA Expands List Of Remote Monitoring Devices That Don’t Need Premarket Notification
The US agency has added gaseous-phase carbon-dioxide gas analyzers to its list of products that – during the coronavirus pandemic – will not require a new premarket notification to be marketed for remote monitoring.
Biden Extends Helping Hand To Small US Manufacturers, Vendors With ‘Made In America’ EO
The president’s executive order aims to give smaller companies a leg up over foreign competitors, among other objectives.
Lawyer: Biden Reg Freeze Puts On Ice Potential Premarket Review Waivers For 84 Device Types
King & Spalding partner Kyle Sampson tells Medtech Insight that a joint US HHS/FDA notice that could exempt a plethora of medical devices from premarket review falls under a recent regulatory freeze from the Biden administration.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: